Lakefront Biotherapeutics (LKFT) Research & Development (2016 - 2026)
Lakefront Biotherapeutics (LKFT) recorded Research & Development of -$36.25 million in the quarter ended Mar 31, 2026, compared with -$192.23 million a year earlier.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Research & Development (2016 - 2026) Analysis & Trends
On a TTM basis, Lakefront Biotherapeutics' Research & Development came in at -$534.62 billion as of Mar 31, 2026; for the year ended Dec 31, 2025, it was -$519.06 billion.
- Across earlier years, Research & Development came in at -$363.08 billion in the year ended Dec 31, 2024, -$259.62 billion in the year ended Dec 31, 2023, -$284.35 billion in the year ended Dec 31, 2022 and -$379.28 million in the year ended Dec 31, 2021.
- Quarterly Research & Development has ranged from -$534.38 billion in the quarter ended Dec 31, 2025 to $192.7 million in the quarter ended Jun 30, 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$534.38 billion (quarter ended Dec 31, 2025), -$396.77 million (quarter ended Sep 30, 2025) and $192.7 million (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Lakefront Biotherapeutics | 2.19 Bn | 1.29 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 36.25 Mn |
| Dec 31, 2025 | 125.15 Mn |
| Sep 30, 2025 | 396.77 Mn |
| Jun 30, 2025 | -192.70 Mn |
| Mar 31, 2025 | 192.23 Mn |
| Dec 31, 2024 | 103.86 Mn |
| Sep 30, 2024 | 249.29 Mn |
| Jun 30, 2024 | -64.97 Mn |
| Mar 31, 2024 | 77.80 Mn |
| Dec 31, 2023 | 79.71 Mn |
| Mar 31, 2023 | 56.41 Mn |
| Dec 31, 2022 | -96.18 Mn |
| Mar 31, 2022 | 112.15 Mn |
| Jun 30, 2021 | 167.23 Mn |
| Mar 31, 2021 | 156.76 Mn |
| Jun 30, 2020 | 162.41 Mn |
| Mar 31, 2020 | 128.90 Mn |
| Dec 31, 2019 | 134.87 Mn |
| Sep 30, 2019 | 134.28 Mn |
| Jun 30, 2019 | 106.04 Mn |
API Access
Lakefront Biotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();